Who knows what is going on behind the curtains Jay Flatley with Illumina (and ties to JUNO and MSK) already stated $100-$200 Billion in exosome revenues are in play....so how much bigger is PS Targeting? Illumina gets their IP from Sequenom and as with the passing of the late Dr Phil Thorpe there also was a passing surrounding Sequenom and as all were forced to start over from scratch with new management ......sounds familiar here with new management and many say Peregrine has to keep starting over https://www.cbsnews.com/news/death-of-an-insider-rd-chief-passes-before-she-can-testify-in-stock-fraud-case/